EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | 0.0% | 113 | -7.4% | 0.00% | – |
| Q3 2019 | $7,000 | +250.0% | 122 | +190.5% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 42 | -44.0% | 0.00% | – |
| Q4 2018 | $3,000 | -70.0% | 75 | -47.2% | 0.00% | – |
| Q3 2018 | $10,000 | -94.4% | 142 | -95.8% | 0.00% | -100.0% |
| Q2 2018 | $178,000 | 0.0% | 3,399 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $178,000 | -0.6% | 3,399 | +1.5% | 0.00% | 0.0% |
| Q4 2017 | $179,000 | -11.8% | 3,349 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $203,000 | -22.2% | 3,349 | +0.9% | 0.00% | -33.3% |
| Q2 2017 | $261,000 | -4.7% | 3,318 | +0.5% | 0.00% | 0.0% |
| Q1 2017 | $274,000 | +4.6% | 3,300 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $262,000 | +13.4% | 3,300 | 0.0% | 0.00% | +33.3% |
| Q3 2016 | $231,000 | +75.0% | 3,300 | -1.5% | 0.00% | +50.0% |
| Q2 2016 | $132,000 | +6500.0% | 3,350 | +6600.0% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 50 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | -87.9% | 50 | -87.7% | 0.00% | -100.0% |
| Q2 2015 | $33,000 | – | 405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |